Browsing publications by Fiona Girdler

Newcastle AuthorsTitleYearFull text
Fiona Girdler
Dr Ian Brotherick
Professor Thomas Lennard
Dr James Young
Dr Brian Shenton
et al.
Changes in the expression of oestrogen receptors (ER alpha and ER beta) in the MCF7 cell line with endocrine treatments2002
Fiona Girdler
Dr Ian Brotherick
William Cunliffe
Professor Thomas Lennard
Dr Brian Shenton
et al.
ER alpha and ER alpha exon5 expression in tamoxifen treated tumours2002
Dr Ian Brotherick
Susan Stamp
William Cunliffe
Dr Gail Higginbottom
Dr James Young
et al.
Neoadjuvant tamoxifen treatment and its effect on MUC1 expression in primary breast cancer2002
Dr Ian Brotherick
Susan Stamp
Fiona Girdler
William Cunliffe
Professor Thomas Lennard
et al.
The influence of tamoxifen treatment on E-cadherin expression in primary breast cancer2002
Fiona Girdler
Dr Ian Brotherick
William Cunliffe
Professor Thomas Lennard
Dr James Young
et al.
Three weeks of tamoxifen treatment alters the expression of ER alpha, ER beta and pS22002
Fiona Girdler
Dr Ian Brotherick
Dr Brian Shenton
ARMS (TM) allele-specific amplification-based detection of mutant p53 DNA and mRNA in tumors of the breast2001
Fiona Girdler
Dr Ian Brotherick
Professor Thomas Lennard
Dr James Young
Dr Brian Shenton
et al.
Changes in the expression of oestrogen receptors (ER alpha and ER beta) in the MCF7 cell line with endocrine treatments.2001
Dr Ian Brotherick
Fiona Girdler
Dr Brian Shenton
The variation in expression of cytokeratin phenotypes in primary breast cancer2001
Fiona Girdler
Dr Ian Brotherick
William Cunliffe
Professor Thomas Lennard
Dr James Young
et al.
Three weeks of tamoxifen treatment alters the expression of ER alpha, ER beta and pS2.2001
Fiona Girdler
Dr Brian Shenton
Dr James Young
Dr Ian Brotherick
Use of the monoclonal antibody DAKO-ERĪ² (8D5-1) to measure oestrogen receptor beta in breast cancer cells2001
12